Pulmotect, Inc.
  • Home
  • About Us
    • Our Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Our Approach
    • Overview
    • Our Science
    • Our Pipeline
    • Published Journal Articles
  • News
  • Contact Us

Houston biotech co.’s coronavirus treatment candidate to undergo clinical trials

Posted on March 30, 2020 by Brenton Scott
Posted in News Coverage

Post navigation

Houston researchers test lung inhalant that could protect healthcare workers from COVID-19
Houston company working on possible COVID-19 treatment
Pulmotect Inc

3900 Essex Ln, Suite 575
Houston, TX 77027
Contact Us

© 2025
Pulmotect, Inc.